Full Enrollment of Phase 3 4WARD Trial Expected in 2H25 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is currently evaluating mavorixafor in a Phase 3 clinical trial in chronic neutropenia (CN ...

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for extensive-stage small cell lung cancer. The PD-L1 and VEGF-A bispecific antibody ...

The markers of inflammation of the first blood test performed at admittance were also collected: CRP, fibrinogen, ferritin, lactate dehydrogenase (LDH), PCT, IL-6, D-dimer, and complete blood count.

Given these findings, a practical approach is to monitor white blood cell (WBC) count with a differential (including absolute neutrophil count) once a week in patients who are receiving vancomycin ...

Neutropenia is a condition characterized by lower-than-normal levels of neutrophils, a type of white blood cell essential for combating infections. Causes of neutropenia include chemotherapy and ...

In an interview with BusinessTech, Mbeki calls the GNU “the ANC in drag,” because he says it has not departed from policies that have long benefited the African middle class to the exclusion ...

The ANC NEC member stressed the need for government to engage with the US to safeguard South Africa’s position in AGOA.

Neutrophils play a crucial role in the immune response, acting as the most abundant white blood cells responsible for frontline defense against infections ...

including clinical results from the completed Phase 2 clinical trial and research focused on assessing the ability of mavorixafor monotherapy to durably increase absolute neutrophil count in ...

The ANC's sub-committee on economic transformation will brief the public on Saturday on the budget proposals and what it calls disinformation from right-wing forces. FILE: Day 1 of a three-day ANC ...